Keywords: fda, accepts, nda, kissei, bph, drug, japanese

FDA accepts NDA for Kissei's BPH drug

Article | 25 February 2008

Print This

Japanese drugmaker Kissei says that a New Drug Application for its benign prostatic hyperplastic drug silodosin (sold as Urief in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in